IL17A and sarcoidosis: A recent study found chloroquine, a drug commonly used in the treatment of autoimmune disease, could reduce HIF-1α levels in sarcoidosis alveolar macrophages and reduce IL-17 and IL-1β production in sarcoidosis PBMC in response to anti-CD3 (33).